[{"NetIncomeLoss_1_Q2_USD":-11717.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":11717.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":3737500.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":125000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":25000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":0.0,"DueToRelatedPartiesCurrent_0_Q2_USD":63410.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"Assets_0_Q2_USD":211326.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":211326.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.0,"DeferredOfferingCosts_0_Q2_USD":211326.0,"StockholdersEquity_0_Q2_USD":13283.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-11717.0,"PaymentsForUnderwritingExpense_1_Q2_USD":3000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":198043.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q2_USD":0.0,"AccountsPayableCurrent_0_Q2_USD":9633.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":0.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q2_USD":11717.0,"AdditionalPaidInCapital_0_Q2_USD":24626.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"Cash_0_Q2_USD":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"Ticker":"NAUT","CIK":"1808805","name":"ARYA SCIENCES ACQUISITION CORP III","OfficialName":"Nautilus Biotechnolgy Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"491482396.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200918"}]